| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
|
10,690 |
9,576 |
$2.40M |
| 99284 |
|
9,274 |
8,157 |
$2.28M |
| 99285 |
|
4,828 |
4,258 |
$1.41M |
| 96361 |
|
4,198 |
3,555 |
$936K |
| 74177 |
|
2,577 |
2,328 |
$741K |
| 70450 |
|
2,218 |
1,972 |
$536K |
| 99282 |
|
2,446 |
2,164 |
$479K |
| 0241U |
|
3,044 |
2,859 |
$342K |
| G0378 |
Hospital observation service, per hour |
2,133 |
960 |
$255K |
| 96360 |
|
1,020 |
895 |
$178K |
| 43239 |
|
215 |
170 |
$141K |
| 96365 |
|
1,198 |
965 |
$135K |
| 71275 |
|
364 |
337 |
$127K |
| 97110 |
|
1,596 |
421 |
$95K |
| 76705 |
|
603 |
557 |
$78K |
| 74176 |
|
237 |
214 |
$77K |
| 99281 |
|
195 |
185 |
$65K |
| 94640 |
|
1,140 |
947 |
$56K |
| 80307 |
|
1,008 |
884 |
$53K |
| 41899 |
|
44 |
36 |
$48K |
| 71046 |
|
2,110 |
1,895 |
$46K |
| 80053 |
|
11,405 |
9,608 |
$40K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,100 |
1,887 |
$39K |
| 77067 |
|
547 |
527 |
$31K |
| 76830 |
|
235 |
221 |
$26K |
| 76642 |
|
128 |
116 |
$26K |
| 77063 |
|
405 |
391 |
$25K |
| J3490 |
Unclassified drugs |
29,290 |
9,614 |
$23K |
| 76856 |
|
94 |
92 |
$19K |
| 80048 |
|
3,041 |
2,227 |
$16K |
| 97161 |
|
159 |
151 |
$11K |
| 93005 |
|
4,596 |
3,838 |
$9K |
| 71045 |
|
3,999 |
3,490 |
$7K |
| 85025 |
|
12,030 |
9,949 |
$6K |
| 87420 |
|
301 |
279 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,923 |
6,159 |
$6K |
| 45380 |
|
14 |
12 |
$5K |
| 84484 |
|
4,168 |
2,907 |
$5K |
| 0202U |
|
155 |
148 |
$5K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
964 |
848 |
$4K |
| 72125 |
|
172 |
166 |
$4K |
| 72148 |
|
14 |
13 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
941 |
824 |
$4K |
| 85027 |
|
2,701 |
2,027 |
$3K |
| 93971 |
|
15 |
15 |
$3K |
| 76770 |
|
14 |
12 |
$3K |
| 97530 |
|
29 |
12 |
$3K |
| 88305 |
|
1,651 |
969 |
$3K |
| 76536 |
|
13 |
12 |
$3K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
180 |
160 |
$2K |
| 96374 |
|
6,517 |
5,626 |
$2K |
| 80299 |
|
436 |
346 |
$2K |
| 87040 |
|
322 |
180 |
$2K |
| 85379 |
|
506 |
460 |
$2K |
| 80143 |
|
254 |
220 |
$2K |
| 87502 |
|
117 |
110 |
$2K |
| 77062 |
|
16 |
16 |
$2K |
| 96366 |
|
13 |
12 |
$2K |
| 87631 |
|
128 |
118 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,561 |
4,427 |
$1K |
| 87637 |
|
112 |
94 |
$1K |
| 96375 |
|
5,159 |
4,073 |
$1K |
| 87086 |
|
2,873 |
2,518 |
$1K |
| 82962 |
|
1,193 |
654 |
$1K |
| 74018 |
|
57 |
53 |
$1K |
| 73630 |
|
115 |
107 |
$1K |
| 81001 |
|
2,738 |
2,418 |
$987.32 |
| 73030 |
|
40 |
36 |
$973.34 |
| 83735 |
|
3,599 |
2,770 |
$968.25 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,194 |
1,803 |
$878.41 |
| 80179 |
|
283 |
250 |
$871.65 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
117 |
93 |
$855.48 |
| 77066 |
Tomosynthesis, mammo |
17 |
17 |
$768.02 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,494 |
3,686 |
$743.99 |
| 84443 |
|
284 |
256 |
$691.30 |
| 85610 |
|
1,671 |
1,420 |
$624.62 |
| 76817 |
|
14 |
12 |
$573.29 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,644 |
1,950 |
$567.62 |
| 97165 |
|
14 |
14 |
$551.30 |
| 73610 |
|
66 |
63 |
$521.38 |
| 81003 |
|
2,710 |
2,429 |
$508.62 |
| 83690 |
|
3,631 |
3,109 |
$467.21 |
| 87804 |
|
1,080 |
962 |
$463.27 |
| 96376 |
|
1,817 |
1,132 |
$443.50 |
| 84703 |
|
2,219 |
2,037 |
$440.19 |
| 73564 |
|
33 |
29 |
$426.31 |
| 83880 |
|
276 |
241 |
$417.86 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,473 |
2,025 |
$411.88 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,609 |
3,675 |
$404.36 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,536 |
1,904 |
$360.07 |
| 81025 |
|
1,688 |
1,529 |
$335.92 |
| 36415 |
|
169 |
149 |
$332.49 |
| 83036 |
|
113 |
102 |
$271.95 |
| 87430 |
|
772 |
713 |
$240.20 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
16 |
13 |
$205.66 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
16 |
$205.31 |
| 96372 |
|
1,978 |
1,554 |
$194.15 |
| 86901 |
|
404 |
306 |
$191.12 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,386 |
1,681 |
$188.05 |
| 83605 |
|
540 |
431 |
$170.01 |
| 84702 |
|
301 |
256 |
$153.89 |
| 87070 |
|
806 |
739 |
$153.18 |
| 87591 |
|
12 |
12 |
$143.51 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,682 |
778 |
$137.57 |
| 86900 |
|
203 |
155 |
$135.65 |
| 88342 |
|
103 |
77 |
$115.73 |
| 85730 |
|
259 |
244 |
$102.88 |
| 87880 |
|
428 |
412 |
$93.16 |
| 87491 |
|
12 |
12 |
$70.98 |
| 73562 |
|
14 |
12 |
$70.54 |
| 87150 |
|
22 |
14 |
$57.99 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
881 |
614 |
$49.63 |
| J2704 |
Injection, propofol, 10 mg |
3,272 |
2,553 |
$47.02 |
| 87186 |
|
331 |
288 |
$46.76 |
| 87081 |
|
229 |
187 |
$35.39 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
568 |
478 |
$33.33 |
| 82150 |
|
194 |
176 |
$26.34 |
| 85007 |
|
13 |
13 |
$21.78 |
| 86850 |
|
15 |
14 |
$19.04 |
| 87205 |
|
23 |
14 |
$15.25 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
495 |
305 |
$14.89 |
| 82550 |
|
31 |
29 |
$12.36 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
483 |
369 |
$12.21 |
| A9270 |
Non-covered item or service |
3,778 |
677 |
$6.12 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
122 |
108 |
$4.30 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
15 |
13 |
$2.70 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
12 |
$2.07 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
234 |
199 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
424 |
295 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
142 |
102 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
86 |
80 |
$0.00 |
| 88360 |
|
15 |
12 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
18 |
12 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
14 |
13 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
20 |
12 |
$0.00 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
82 |
42 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
290 |
275 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
60 |
54 |
$0.00 |
| 87635 |
|
13 |
13 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
45 |
41 |
$0.00 |